Can public education campaigns equitably counter the use of substandard and falsified medical products in African countries?

导出 OA

翻译打印收藏纠错

第一作者： Janelle M,Wagnild

第一单位： Department of Anthropology, Durham University, South Road, Durham DH1 3LE, UK.

作者： Janelle M,Wagnild ^[1] ; Samuel Asiedu,Owusu ^[2] ; Simon,Mariwah ^[3] ; Victor I,Kolo ^[4] ; Ahmed,Vandi ^[5] ; Didacus Bambaiha,Namanya ^[6] ; Rutendo,Kuwana ^[7] ; Babatunde,Jayeola ^[8] ; Vigil,Prah-Ashun ^[9] ; Moji Christianah,Adeyeye ^[10] ; James,Komeh ^[11] ; David,Nahamya ^[12] ; Kate,Hampshire ^[1]

作者单位： Department of Anthropology, Durham University, South Road, Durham DH1 3LE, UK. ^[1] Directorate of Research, Innovation and Consultancy, University of Cape Coast, New Administration Block, Cape Coast, Ghana. ^[2] Department of Geography and Regional Planning, University of Cape Coast, Faculty of Social Sciences, Cape Coast, Ghana. ^[3] School of Public Health, University of Medical Sciences, Ondo City, Ondo State PMB 536, Nigeria. ^[4] Department of Community Health and Clinical Sciences, Njala University, Bo Campus, Bo, Sierra Leone. ^[5] Ministry of Health, PO Box 7272, Lourdel Road, Kampala, Uganda. ^[6] Incidents and Substandard/Falsified Medical Products Team, World Health Organization, Avenue Appia 20, Geneva 1211, Switzerland. ^[7] World Health Organization, Cité du Djoué, P.O.Box 06, Brazzaville, Republic of Congo. ^[8] Food and Drugs Authority, 17 Nelson Mandela Ave, Accra, Ghana. ^[9] National Agency for Food and Drug Administration and Control, Plot 2032, Olusegun, Obasanjo Way, Zone 7, Wuse, Abuja, Nigeria. ^[10] Pharmacy Board of Sierra Leone, New England Ville, Freetown, Sierra Leone. ^[11] National Drug Authority, PO Box 23096, Kampala, Uganda. ^[12]

关键词 Ghana Nigeria Sierra Leone Uganda medicine quality risk communication